0001104659-15-049025.txt : 20150630 0001104659-15-049025.hdr.sgml : 20150630 20150630184803 ACCESSION NUMBER: 0001104659-15-049025 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150630 FILED AS OF DATE: 20150630 DATE AS OF CHANGE: 20150630 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CATABASIS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001454789 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE KENDALL SQUARE STREET 2: BLDG. 1400E, SUITE B14202 CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-349-1971 MAIL ADDRESS: STREET 1: ONE KENDALL SQUARE STREET 2: BLDG. 1400E, SUITE B14202 CITY: CAMBRIDGE STATE: MA ZIP: 02139 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Jirousek Michael CENTRAL INDEX KEY: 0001394939 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37467 FILM NUMBER: 15962734 MAIL ADDRESS: STREET 1: C/O SIRTRIS PHARMACEUTICALS, INC. STREET 2: 790 MEMORIAL DR. SUITE 104 CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 a4.xml 4 X0306 4 2015-06-30 0 0001454789 CATABASIS PHARMACEUTICALS INC CATB 0001394939 Jirousek Michael C/O CATABASIS PHARMACEUTICALS, INC. ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139 0 1 0 0 Chief Scientific Officer Common Stock 2015-06-30 4 C 0 66658 A 245684 D Common Stock 2015-06-30 4 C 0 409 A 246093 D Series A Preferred Stock 2015-06-30 4 C 0 856571 0 D Common Stock 66658 0 D Series B Preferred Stock 2015-06-30 4 C 0 5261 0 D Common Stock 409 0 D The Series A and Series B Preferred Stock converted into Common Stock on a 1-for-12.85 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A and B Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date. /s/ Michael Jirousek 2015-06-30